ID

39496

Beschreibung

Acetazolamide and Spironolactone to Increase Natriuresis in Congestive Heart Failure; ODM derived from: https://clinicaltrials.gov/show/NCT01973335

Link

https://clinicaltrials.gov/show/NCT01973335

Stichworte

Versionen (1)
  1. 19.01.20 19.01.20 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

19. Januar 2020

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Heart Failure NCT01973335

Englisch

Eligibility Heart Failure NCT01973335

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
older than 18 years and able to give informed consent
Beschreibung

Age | Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0021430
clinical diagnosis of acute decompensated heart failure within the previous 8 h
Beschreibung

Decompensated cardiac failure Recent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0581377
UMLS CUI [1,2]
C0332185
at least two clinical signs of congestion (edema, ascites, jugular venous distension, or pulmonary vascular congestion on chest radiography)
Beschreibung

Sign or Symptom Quantity Congestion | Edema Chest X-ray | Ascites Chest X-ray | Jugular venous engorgement Chest X-ray | Pulmonary congestion Vascular Chest X-ray

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3540840
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0700148
UMLS CUI [2,1]
C0013604
UMLS CUI [2,2]
C0039985
UMLS CUI [3,1]
C0003962
UMLS CUI [3,2]
C0039985
UMLS CUI [4,1]
C0425687
UMLS CUI [4,2]
C0039985
UMLS CUI [5,1]
C0242073
UMLS CUI [5,2]
C1801960
UMLS CUI [5,3]
C0039985
maintenance therapy with oral loop diuretics at a dose of at least 1 mg bumetanide (1 mg bumetanide = 40 mg furosemide = 20 mg torsemide) for at least 1 month before hospital admission
Beschreibung

Maintenance therapy | Loop Diuretics Oral | Bumetanide Dose | Equivalent Furosemide Dose | Equivalent Torsemide Dose

Datentyp

boolean

Alias
UMLS CUI [1]
C0677908
UMLS CUI [2,1]
C0354100
UMLS CUI [2,2]
C1527415
UMLS CUI [3,1]
C0006376
UMLS CUI [3,2]
C0178602
UMLS CUI [4,1]
C0205163
UMLS CUI [4,2]
C0016860
UMLS CUI [4,3]
C0178602
UMLS CUI [5,1]
C0205163
UMLS CUI [5,2]
C0076840
UMLS CUI [5,3]
C0178602
nt-probnp >1000 ng/l
Beschreibung

N-Terminal ProB-type Natriuretic Peptide Measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C3272900
left ventricular ejection fraction <50%
Beschreibung

Left ventricular ejection fraction

Datentyp

boolean

Alias
UMLS CUI [1]
C0428772
at least one out of three of the following criteria:
Beschreibung

Criteria Quantity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C1265611
serum sodium <136 mmol/l
Beschreibung

Serum sodium measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0523891
serum urea/creatinine ratio >50 (comparable to a bun/creatinine ratio >25)
Beschreibung

Urea to Creatinine Ratio Measurement | Comparison BUN/Creatinine ratio

Datentyp

boolean

Alias
UMLS CUI [1]
C3272926
UMLS CUI [2,1]
C1707455
UMLS CUI [2,2]
C0201922
admission serum creatinine increased with >0.3 mg/dl compared to previous value within 3 months before admission
Beschreibung

Serum creatinine raised

Datentyp

boolean

Alias
UMLS CUI [1]
C0700225
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of cardiac transplantation and/or ventricular assist device
Beschreibung

Heart Transplantation | Artificial Ventricle

Datentyp

boolean

Alias
UMLS CUI [1]
C0018823
UMLS CUI [2]
C0085842
concurrent diagnosis of an acute coronary syndrome defined as typical chest pain and/or electrocardiographic changes in addition to a troponin rise >99th percentile
Beschreibung

Acute Coronary Syndrome | Chest Pain Typical | Electrocardiographic changes In addition to Troponin increased

Datentyp

boolean

Alias
UMLS CUI [1]
C0948089
UMLS CUI [2,1]
C0008031
UMLS CUI [2,2]
C3538928
UMLS CUI [3,1]
C0855329
UMLS CUI [3,2]
C0332287
UMLS CUI [3,3]
C1141948
mean arterial blood pressure <65 mmhg, or systolic blood pressure <90 mmhg at the moment of admission
Beschreibung

Mean blood pressure | Systolic Pressure

Datentyp

boolean

Alias
UMLS CUI [1]
C0428886
UMLS CUI [2]
C0871470
use of intravenous inotropes, vasopressors or nitroprusside at any time point during the study
Beschreibung

Inotropic agent Intravenous | Vasoconstrictor Agents | Nitroprusside

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0304509
UMLS CUI [1,2]
C1522726
UMLS CUI [2]
C0042397
UMLS CUI [3]
C0028193
a baseline estimated glomerular filtration rate <15 ml/min/1.73m² according to the chronic kidney disease epidemiology collaboration (ckd-epi) formula at the moment of inclusion
Beschreibung

Estimated Glomerular Filtration Rate CKD-EPI

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3811844
UMLS CUI [1,2]
C2964649
use of renal replacement therapy or ultrafiltration before study inclusion
Beschreibung

Renal Replacement Therapy | Ultrafiltration

Datentyp

boolean

Alias
UMLS CUI [1]
C0206074
UMLS CUI [2]
C0041612
treatment with acetazolamide within the previous month
Beschreibung

Acetazolamide

Datentyp

boolean

Alias
UMLS CUI [1]
C0000981
treatment with ≥2 mg bumetanide or an equivalent dose during the index hospitalization before randomization
Beschreibung

Bumetanide Dose | Equivalent Dose

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0006376
UMLS CUI [1,2]
C0178602
UMLS CUI [2,1]
C0205163
UMLS CUI [2,2]
C0178602
use of diuretics, vasopressin antagonists or mineralocorticoid receptor antagonist not specified by the protocol
Beschreibung

Diuretics | Vasopressin Antagonist | Mineralocorticoid Receptor Antagonists

Datentyp

boolean

Alias
UMLS CUI [1]
C0012798
UMLS CUI [2]
C3537128
UMLS CUI [3]
C1579268
exposure to nephrotoxic agents (i.e. contrast dye) anticipated within 3 days
Beschreibung

Exposure to Agent Nephrotoxic | Exposure to Contrast dye

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0332157
UMLS CUI [1,2]
C1254351
UMLS CUI [1,3]
C1514118
UMLS CUI [2,1]
C0332157
UMLS CUI [2,2]
C0742795
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Heart Failure NCT01973335

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age | Informed Consent
Item
older than 18 years and able to give informed consent
boolean
C0001779 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
Decompensated cardiac failure Recent
Item
clinical diagnosis of acute decompensated heart failure within the previous 8 h
boolean
C0581377 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
Sign or Symptom Quantity Congestion | Edema Chest X-ray | Ascites Chest X-ray | Jugular venous engorgement Chest X-ray | Pulmonary congestion Vascular Chest X-ray
Item
at least two clinical signs of congestion (edema, ascites, jugular venous distension, or pulmonary vascular congestion on chest radiography)
boolean
C3540840 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0700148 (UMLS CUI [1,3])
C0013604 (UMLS CUI [2,1])
C0039985 (UMLS CUI [2,2])
C0003962 (UMLS CUI [3,1])
C0039985 (UMLS CUI [3,2])
C0425687 (UMLS CUI [4,1])
C0039985 (UMLS CUI [4,2])
C0242073 (UMLS CUI [5,1])
C1801960 (UMLS CUI [5,2])
C0039985 (UMLS CUI [5,3])
Maintenance therapy | Loop Diuretics Oral | Bumetanide Dose | Equivalent Furosemide Dose | Equivalent Torsemide Dose
Item
maintenance therapy with oral loop diuretics at a dose of at least 1 mg bumetanide (1 mg bumetanide = 40 mg furosemide = 20 mg torsemide) for at least 1 month before hospital admission
boolean
C0677908 (UMLS CUI [1])
C0354100 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0006376 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0205163 (UMLS CUI [4,1])
C0016860 (UMLS CUI [4,2])
C0178602 (UMLS CUI [4,3])
C0205163 (UMLS CUI [5,1])
C0076840 (UMLS CUI [5,2])
C0178602 (UMLS CUI [5,3])
N-Terminal ProB-type Natriuretic Peptide Measurement
Item
nt-probnp >1000 ng/l
boolean
C3272900 (UMLS CUI [1])
Left ventricular ejection fraction
Item
left ventricular ejection fraction <50%
boolean
C0428772 (UMLS CUI [1])
Criteria Quantity
Item
at least one out of three of the following criteria:
boolean
C0243161 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Serum sodium measurement
Item
serum sodium <136 mmol/l
boolean
C0523891 (UMLS CUI [1])
Urea to Creatinine Ratio Measurement | Comparison BUN/Creatinine ratio
Item
serum urea/creatinine ratio >50 (comparable to a bun/creatinine ratio >25)
boolean
C3272926 (UMLS CUI [1])
C1707455 (UMLS CUI [2,1])
C0201922 (UMLS CUI [2,2])
Serum creatinine raised
Item
admission serum creatinine increased with >0.3 mg/dl compared to previous value within 3 months before admission
boolean
C0700225 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Heart Transplantation | Artificial Ventricle
Item
history of cardiac transplantation and/or ventricular assist device
boolean
C0018823 (UMLS CUI [1])
C0085842 (UMLS CUI [2])
Acute Coronary Syndrome | Chest Pain Typical | Electrocardiographic changes In addition to Troponin increased
Item
concurrent diagnosis of an acute coronary syndrome defined as typical chest pain and/or electrocardiographic changes in addition to a troponin rise >99th percentile
boolean
C0948089 (UMLS CUI [1])
C0008031 (UMLS CUI [2,1])
C3538928 (UMLS CUI [2,2])
C0855329 (UMLS CUI [3,1])
C0332287 (UMLS CUI [3,2])
C1141948 (UMLS CUI [3,3])
Mean blood pressure | Systolic Pressure
Item
mean arterial blood pressure <65 mmhg, or systolic blood pressure <90 mmhg at the moment of admission
boolean
C0428886 (UMLS CUI [1])
C0871470 (UMLS CUI [2])
Inotropic agent Intravenous | Vasoconstrictor Agents | Nitroprusside
Item
use of intravenous inotropes, vasopressors or nitroprusside at any time point during the study
boolean
C0304509 (UMLS CUI [1,1])
C1522726 (UMLS CUI [1,2])
C0042397 (UMLS CUI [2])
C0028193 (UMLS CUI [3])
Estimated Glomerular Filtration Rate CKD-EPI
Item
a baseline estimated glomerular filtration rate <15 ml/min/1.73m² according to the chronic kidney disease epidemiology collaboration (ckd-epi) formula at the moment of inclusion
boolean
C3811844 (UMLS CUI [1,1])
C2964649 (UMLS CUI [1,2])
Renal Replacement Therapy | Ultrafiltration
Item
use of renal replacement therapy or ultrafiltration before study inclusion
boolean
C0206074 (UMLS CUI [1])
C0041612 (UMLS CUI [2])
Acetazolamide
Item
treatment with acetazolamide within the previous month
boolean
C0000981 (UMLS CUI [1])
Bumetanide Dose | Equivalent Dose
Item
treatment with ≥2 mg bumetanide or an equivalent dose during the index hospitalization before randomization
boolean
C0006376 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205163 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
Diuretics | Vasopressin Antagonist | Mineralocorticoid Receptor Antagonists
Item
use of diuretics, vasopressin antagonists or mineralocorticoid receptor antagonist not specified by the protocol
boolean
C0012798 (UMLS CUI [1])
C3537128 (UMLS CUI [2])
C1579268 (UMLS CUI [3])
Exposure to Agent Nephrotoxic | Exposure to Contrast dye
Item
exposure to nephrotoxic agents (i.e. contrast dye) anticipated within 3 days
boolean
C0332157 (UMLS CUI [1,1])
C1254351 (UMLS CUI [1,2])
C1514118 (UMLS CUI [1,3])
C0332157 (UMLS CUI [2,1])
C0742795 (UMLS CUI [2,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video